Geneos Wealth Management’s Procore PCOR Stock Holding History

Geneos Wealth Management’s Portfolio PCOR Stock Details PCOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-10	Closed	-$822	–	2152
2024 Q1	$822	Buy	+10	New	+$742	﹤0.01%	2065

Other funds holding PCOR

Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

XN LP New York $2.72B AUM 46.67% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return

Geneos Wealth Management's PCOR Position: Q2 2024 in Review

Geneos Wealth Management sold out of Procore (PCOR) in Q2 2024, closing a stake of 10 shares — an estimated $822 sold.

Geneos Wealth Management first reported a position in PCOR in Q1 2024 and held it in 1 quarter. The position peaked at $822 in Q1 2024. 393 funds tracked by Wall St. Rank hold PCOR as of Q2 2024.

Geneos Wealth Management reported no remaining Procore position as of Q2 2024 after selling out during the quarter.
Geneos Wealth Management sold 10 Procore shares in Q2 2024, an estimated $822.
Geneos Wealth Management first reported a position in Procore in Q1 2024 and held it in 1 quarter.
Geneos Wealth Management's Procore position peaked at $822 in Q1 2024.
393 funds tracked by Wall St. Rank held Procore as of Q2 2024.

Based on Geneos Wealth Management's 13F filing for Q2 2024, filed 23 Jul 2024.